Skandinaviska Enskilda Banken AB »

Intra Cellular Therapies shares owned by Skandinaviska Enskilda Banken AB

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Skandinaviska Enskilda Banken AB from 13F filings

Historical chart of Skandinaviska Enskilda Banken AB investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Skandinaviska Enskilda Banken AB

Quarter filed Position value Share count Share price at filing
2024-09-30 $20M 279k 73.17
2024-03-31 $9.0M 130k 69.10
2023-09-30 $21M 404k 52.08
2023-06-30 $26M 404k 63.31
2023-03-31 $15M 268k 54.11
2022-12-31 $20M 373k 52.95
2022-09-30 $18M 384k 46.50
2022-06-30 $22M 384k 57.05
2022-03-31 $24M 392k 61.16
2021-12-31 $21M 396k 52.15
2021-09-30 $11M 293k 37.22
2021-06-30 $12M 293k 40.82
2021-03-31 $874k 26k 33.98